The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT

被引:265
作者
Huynh, KD
Bardwell, VJ
机构
[1] Univ Minnesota, Dept Biochem, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Biochem Mol Biol & Biophys Program, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Ctr Canc, Minneapolis, MN 55455 USA
[4] Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA
关键词
POZ domain; BCL-6; transcriptional repression; N-CoR; SMRT;
D O I
10.1038/sj.onc.1202197
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Virtually all diffuse large cell lymphomas and a significant fraction of follicular lymphomas contain translocations and/or point mutations in the 5' noncoding region of the putative oncogene BCL-6, that are presumed to deregulate its expression. BCL-6 encodes a Cys(2)-His(2) zinc finger transcriptional repressor with a POZ domain at its amino-terminus, The POZ (or BTB) domain, a 120-amino-acid motif, mediates homomeric and, in some proteins, heteromeric POZ-POZ interactions. In addition, the POZ domain is required for transcriptional repression of several proteins, including BCL-6, Using a yeast two-hybrid screen, we identified N-CoR and SMRT as BCL-6 interacting proteins. Both N-CoR and SMRT, which were originally identified as co-repressors for the unliganded nuclear thyroid hormone and retinoic acid receptors, are components of large complexes containing histone deacetylases, We show that the interaction between BCL-6 and these co-repressors is also detected in the more physiologically relevant mammalian two-hybrid assay. The POZ domain is necessary and sufficient for interaction with these corepressors. BCL-6 and N-CoR co-localize to punctate regions of the nucleus. Furthermore, when BCL-6 is bound to its consensus recognition sequence in vivo, it can interact with N-CoR and SMRT, We find, in vitro, that POZ domains from a variety of other POZ domain-containing proteins, including the transcriptional repressor PLZF, as well as ZID, GAGA and a vaccinia virus protein, SalF17R, also interact with varying affinities with N-CoR and SMRT, We find that BCL-6 POZ domain mutations that disrupt the interaction with N-CoR and SMRT no longer repress transcription. In addition, these mutations no longer self associate suggesting that self interaction is required for interaction with the co-repressors and for repression. More recently N-CoR has also been implicated in transcriptional repression by the Mad/Mxi proteins. Our demonstration that N-CoR and SMRT interact with the POZ domain containing proteins indicates that these co-repressors are likely involved in the mediation of repression by multiple classes of repressors and may explain, in part, how POZ domain containing repressors mediate transcriptional repression.
引用
收藏
页码:2473 / 2484
页数:12
相关论文
共 74 条
  • [41] Role of the histone deacetylase complex in acute promyelocytic leukaemia
    Lin, RJ
    Nagy, L
    Inoue, S
    Shao, WL
    Miller, WH
    Evans, RM
    [J]. NATURE, 1998, 391 (6669) : 811 - 814
  • [42] Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma
    Migliazza, A
    Martinotti, S
    Chen, WY
    Fusco, C
    Ye, BH
    Knowles, DM
    Offit, K
    Chaganti, RSK
    DallaFavera, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (26) : 12520 - 12524
  • [43] MIKI T, 1994, BLOOD, V83, P217
  • [44] PEF-BOS, A POWERFUL MAMMALIAN EXPRESSION VECTOR
    MIZUSHIMA, S
    NAGATA, S
    [J]. NUCLEIC ACIDS RESEARCH, 1990, 18 (17) : 5322 - 5322
  • [45] Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase
    Nagy, L
    Kao, HY
    Chakravarti, D
    Lin, RJ
    Hassig, CA
    Ayer, DE
    Schreiber, SL
    Evans, RM
    [J]. CELL, 1997, 89 (03) : 373 - 380
  • [46] TRANSCRIPTIONAL REPRESSOR ZF5 IDENTIFIES A NEW CONSERVED DOMAIN IN ZINC-FINGER PROTEINS
    NUMOTO, M
    NIWA, O
    KAPLAN, J
    WONG, KK
    MERRELL, K
    KAMIYA, K
    YANAGIHARA, K
    CALAME, K
    [J]. NUCLEIC ACIDS RESEARCH, 1993, 21 (16) : 3767 - 3775
  • [47] REARRANGEMENT OF THE BCL-6 GENE AS A PROGNOSTIC MARKER IN DIFFUSE LARGE-CELL LYMPHOMA
    OFFIT, K
    LOCOCO, F
    LOUIE, DC
    PARSA, NZ
    LEUNG, D
    PORTLOCK, C
    YE, BH
    LISTA, F
    FILIPPA, DA
    ROSENBAUM, A
    LADANYI, M
    JHANWAR, S
    DALLAFAVERA, R
    CHAGANTI, RSK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (02) : 74 - 80
  • [48] HETEROGENEITY IN B-CELL NEOPLASMS ASSOCIATED WITH REARRANGEMENT OF THE LAZ3 GENE ON CHROMOSOME BAND 3Q27
    OHNO, H
    KERCKAERT, JP
    BASTARD, C
    FUKUHARA, S
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1994, 85 (06): : 592 - 600
  • [49] BCL-6 GENE-PRODUCT, A 92-KD TO 98-KD NUCLEAR PHOSPHOPROTEIN, IS HIGHLY EXPRESSED IN GERMINAL CENTER B-CELLS AND THEIR NEOPLASTIC COUNTERPARTS
    ONIZUKA, T
    MORIYAMA, M
    YAMOCHI, T
    KURODA, T
    KAZAMA, A
    KANAZAWA, N
    SATO, K
    KATO, T
    OTA, H
    MORI, S
    [J]. BLOOD, 1995, 86 (01) : 28 - 37
  • [50] ANALYSIS OF LAZ3 (BCL-6) STATUS IN B-CELL NON-HODGKINS-LYMPHOMAS - RESULTS OF REARRANGEMENT AND GENE-EXPRESSION STUDIES AND A MUTATIONAL ANALYSIS OF CODING REGION SEQUENCES
    OTSUKI, T
    YANO, T
    CLARK, HM
    BASTARD, C
    KERCKAERT, JP
    JAFFE, ES
    RAFFELD, M
    [J]. BLOOD, 1995, 85 (10) : 2877 - 2884